Baek, Y., Lee, D., Kim, J., Kim, J., Park, W., Kim, T., . . . Kim, Y. (2016). Arg-Leu-Tyr-Glu tetrapeptide inhibits tumor progression by suppressing angiogenesis and vascular permeability via VEGF receptor-2 antagonism. Oncotarget.
Styl ChicagoBaek, Yi-Yong, et al. "Arg-Leu-Tyr-Glu Tetrapeptide Inhibits Tumor Progression By Suppressing Angiogenesis and Vascular Permeability Via VEGF Receptor-2 Antagonism." Oncotarget 2016.
Citace podle MLABaek, Yi-Yong, et al. "Arg-Leu-Tyr-Glu Tetrapeptide Inhibits Tumor Progression By Suppressing Angiogenesis and Vascular Permeability Via VEGF Receptor-2 Antagonism." Oncotarget 2016.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..